CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 217 filers reported holding CLOVIS ONCOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.27 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,515,000 | -68.0% | 385,403 | +21.1% | 0.02% | -63.9% |
| Q2 2019 | $4,731,000 | +13.4% | 318,146 | +89.3% | 0.06% | +10.9% |
| Q1 2019 | $4,172,000 | +78.6% | 168,107 | +111.3% | 0.06% | +111.5% |
| Q3 2018 | $2,336,000 | -33.7% | 79,549 | +2.7% | 0.03% | -18.8% |
| Q2 2018 | $3,523,000 | – | 77,478 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |